ESC Professional Premium Access

Sub-Saharan Africa's contribution to clinical trials in international acute coronary syndromes and heart failure guidelines

Congress Presentation

About the speaker

Doctor Jonathan Hudson

King's College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure

Speaker: Doctor L. Roberts (Reading, GB)

Thumbnail

Education level and the incidence of heart failure, acute myocardial infarction, and stroke in patients with atrial fibrillation

Speaker: Doctor A. Sztaniszlav (Orebro, SE)

Thumbnail

Association of ticagrelor vs clopidogrel with net adverse clinical events in NSTEMI patients with mild thrombocytopenia

Speaker: Professor K. Chen (Tianjin, CN)

Thumbnail

Factors associated with major adverse cardiovascular events among Arabs and Jews in Israel: a population-based cohort study

Speaker: Associate Professor O. Kalter-Leibovici (Ramat Gan, IL)

Thumbnail

Assessing aortic morphology post aortic valve replacement using unsupervised hierarchical clustering and statistical shape modelling

Speaker: Mr Y. Aljassam (Bristol, GB)

Thumbnail

Access the full session

Cardiovascular risk and interventions: comparisons, disparities, and clinical trials

Speakers: Doctor J. Hudson, Doctor L. Roberts, Doctor A. Sztaniszlav, Professor K. Chen, Associate Professor O. Kalter-Leibovici...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations